Victory Financial Group’s AbbVie ABBV Stock Holding History

Victory Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.23M	Buy	8,863 +281	+3%	+$60.5K	0.23%	71
2026 Q1	$1.87M	Buy	8,582 +876	+11%	+$194K	0.23%	72
2025 Q4	$1.76M	Buy	7,706 +2,141	+38%	+$488K	0.22%	72
2025 Q3	$1.29M	Buy	5,565 +198	+4%	+$40.3K	0.18%	74
2025 Q2	$996K	Buy	5,367 +1,915	+55%	+$356K	0.16%	72
2025 Q1	$755K	Buy	3,452 +1,828	+113%	+$355K	0.15%	78
2024 Q4	$289K	Buy	+1,624	New	+$299K	0.08%	110

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Financial Group's ABBV Position: Q2 2026 in Review

Victory Financial Group increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $60.5K and bringing the position to 8,863 shares worth $2.23M. The position accounts for 0.23% of the portfolio, ranked #71.

Victory Financial Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Victory Financial Group held 8,863 shares of AbbVie worth $2.23M as of Q2 2026.
Victory Financial Group bought 281 AbbVie shares in Q2 2026, an estimated $60.5K.
AbbVie made up 0.23% of Victory Financial Group's portfolio in Q2 2026, its #71 holding.
Victory Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.